Benchmark Maintains Buy on Cineverse, Raises Price Target to $14

Benzinga Newsdesk www.benzinga.com Positive 78.7%

Neg 0% Neu 0% Pos 78.7%

Benchmark analyst Daniel L. Kurnos maintains Cineverse (NASDAQ:CNVS) with a Buy and raises the price target from $12 to $14.